Hemodialysis biomarkers: total advanced glycation end products (AGEs) against oxidized human serum albumin (HSAox).

Annalisa NoceValentina RovellaGiulia MarroneGiada CattaniViviana ZingarettiDolores LimongiCartesio D'AgostiniRoberto SorgeMaurizio CasascoNicola Di DanieleGiorgio RicciAlessio Bocedi

Published in: Acta diabetologica (2019)

HSAox is a simple and immediate method to verify the beneficial effect of a single dialysis session on the redox imbalance, always present in HD patients. Total AGEs assayed by ELISA procedure seem to be a less reliable biomarker in this population.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
human serum albumin
newly diagnosed
prognostic factors
minimally invasive
high intensity
patient reported